Skip to content

Smoker Extracellular Vesicles Influence on Human Bronchial Epithelial Cells

Particulate Air Pollution : Smoker Extracellular Vesicles Influence on Human Bronchial Epithelial Cells

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03608293
Acronym
Aerotox-1
Enrollment
20
Registered
2018-07-31
Start date
2012-01-01
Completion date
2013-12-31
Last updated
2026-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biomarkers, Human Bronchial Epithelial Cells, Lung Pathogenesis, Smokers

Brief summary

Cigarette smoking is a habit that has spread all over the world and is a significant risk factor for many diseases including cardiovascular disease, chronic obstructive pulmonary disease(COPD),asthma and lung cancer. Evaluation and understanding of tobacco health effects are of major interest worldwide and answer to important societal concerns. Identification of new biomarkers of exposure to tobacco smoke potentially implicated in COPD or lung carcinogenesis would allow a better observation of tobacco exposed population, thanks to screening establishment at reversible stages of pathological processes. In this study, the main goal is to study whether cigarettes smoking alters miRNA profiles of extracellular vesicles (EVs) present in human broncho alveolar lavages (BALs), which could affect surrounding normal bronchial epithelial cells status.

Detailed description

Extracellular vesicles (EVs) include a variety of nanoscale membranous vesicles (exosomes, microvesicles, microparticles). EVs are released into the interstitial fluid from a wide variety of normal or diseased cells. Analysis of EVs and their content maybe useful as disease biomarkers as they reflect the contents of cells of origin, differ between normal and diseased tissue and can be reliably detected. EVs may thus act as biomarkers of diverse pathologies like cancer, and detection of these biomarkers maybe applied to early diagnosis or assessment of prognosis in patients with cancer. EVs indeed contain both mRNAs and non-coding RNAs, such as small regulatory microRNAs (miRNAs).

Interventions

DIAGNOSTIC_TESTBroncho Alveolar Lavages (BAL)

BEAS-2 B cells are exposed to EVs isolated from BAL of smokers and non-smokers.

Sponsors

Lille Catholic University
Lead SponsorOTHER
Universite du Littoral Cote d'Opale
CollaboratorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* \>18 year-old

Exclusion criteria

* Lack of informed consent * Drug treatment * Professional exposure * Evolutive pregnancy * Bradycardia * Respiratory assistance required, * Diagnosed respiratory distress (e.g. COPD, asthma) * Infectious pneumopathy * Bronchial cancer

Design outcomes

Primary

MeasureTime frameDescription
Quantification of target mRNA expression in human bronchial epithelial cells (BEAS-2 B) exposed to EVs isolated from LBA of patientsThrough the study completion, an average of 48 monthsQuantitative polymerase chain reaction (RT-qPCR) for determination of mRNA expression

Contacts

PRINCIPAL_INVESTIGATORPierre Gosset, MD

GHICL

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 12, 2026